Pharmacy & Biological Sciences Archives - Page 5 of 8

NIH’s All of Us Research Program Expands National Network of Medical Centers

The program is a bold effort to gather data over time from more than 1M people living in the U.S., with the ultimate goal of accelerating research and improving health.

from NIH

Three sets of health care provider organizations will add to a growing network of trusted leaders charged with implementing the National Institutes of Health’s All of Us Research Program, an ambitious effort to advance research into precision medicine. Combined, the new awardees will receive $13.8 million to enroll interested individuals, gather participant health information and help retain participants in the program through ongoing engagement efforts. These awardees will extend the geographic coverage of the program and strengthen its reach within underserved communities, including lower-income, Hispanic and Latino, African American, American Indian and rural communities.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

The Implications of the Opioid Lawsuits

Opioid manufacturers, drug distributors, and pharmacy chains continue to get hit with lawsuits alleging they fueled the nation’s opioid crisis through deceptive marketing and negligence.

from Axios

It’s not at all clear municipalities will win, but the lawsuits represent something larger — policymakers want more scrutiny and oversight for companies that make and deliver painkillers instead of heaping blame on people who suffer from addiction.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

Advocates Prepare for Rally for Medical Research

Advocates will descend upon Washington, D.C. on September 13th and 14th to discuss the economic and health impact of research supported by the NIH.

from Research America

On September 13-14, advocates from across the country will gather in Washington D.C. to connect with policymakers for discussions on the life-saving research funded by federal investments. The Rally for Medical Research was founded in 2013 as a result of budget sequestration, the automatic spending cuts enacted across all federal government agencies, including the National Institutes of Health (NIH).

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

5 Researchers Share $500,000 Prize for Work on Gene Editing

The recipients of the annual Albany Medical Center Prize in Medicine and Biomedical Research are being recognized for their contributions related to the development of the tool, called CRISPR-Cas9.

from Washington Post

The recipients of the annual Albany Medical Center Prize in Medicine and Biomedical Research were announced Tuesday. They are being recognized for their contributions related to the development of the tool, called CRISPR-Cas9.

The recipients are: Emmanuelle Charpentier of the Max Planck Institute for Infection Biology, Germany; Jennifer Doudna, University of California, Berkeley; Luciano Marraffini, The Rockefeller University, New York City; Francisco J.M. Mojica, University of Alicante, Spain; Feng Zhang, Massachusetts Institute of Technology.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

South Carolina Sues Oxycontin Maker Purdue over Opioid Marketing

The lawsuit by South Carolina Attorney General Alan Wilson, filed in Richland County Court of Common Pleas in Columbia, accuses the company of the unfair and deceptive marketing of opioid painkillers.

from Reuters

South Carolina sued Purdue Pharma LP on Tuesday, becoming the latest state or local government to accuse the OxyContin maker of deceptive marketing practices that have contributed to a national opioid addiction epidemic.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

What’s the Missing Link for STEM Diversity?

The problem isn’t new and it isn’t going away by itself. But it is getting more and more attention. Mainly due to the fact that a diverse science and engineering workforce is absolutely critical for innovation, entrepreneurism, and a competitive national economy.

from World Economic Forum

Although women earn about half the bachelor’s degrees awarded in biology and chemistry, they are underrepresented in all other STEM disciplines – mathematics, computer science, earth sciences, engineering and physics. Women are half the population, but hold only 28% of science and engineering jobs.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

NIH Accelerates the Use of Genomics in Clinical Care

The new grants will support the development of methods needed to integrate genome sequencing into the practice of medicine, improve the discovery and interpretation of genomic variants, and investigate the impact of genome sequencing on healthcare outcomes.

from NIH.gov

The National Institutes of Health (NIH) is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care. The new awards will generate innovative approaches and best practices to ensure that the effectiveness of genomic medicine can be applied to all individuals and groups, including diverse and underserved populations, and in healthcare settings that extend beyond academic medical centers.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

86% of Americans: Healthcare Workers Should Discuss Clinical Trials

While the pharma industry spends upwards of $2B on patient recruitment every year, a recent survey found half of respondents were not aware of clinical trials.

from Research!America

The results of a new public opinion survey conducted by Research!America sheds light on the perception Americans have of clinical trials and may hold the key to the patient recruitment problem. The survey found 86 percent of Americans felt their healthcare professionals should discuss clinical trials with patients diagnosed with a disease, and that those discussions should be part of their standard of care.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

After 15 Years of Failure, What Can Pharma Offer Alzheimer’s Patients?

The most recent new treatment for Alzheimer’s disease was approved by European regulators in May 2002, with the US FDA following suit the next year.

from The Pharma Letter

As patients, physicians and pharma firms digest the latest research, presented at last week’s Alzheimer’s Association International Conference (AAIC), what can the pharmaceutical industry offer the estimated 50 million people living with this most burdensome of conditions?

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes

Top 10 U.S. Biopharma Clusters

All 10 regions ranked have significant assets that make them attractive to biopharma researchers, executives, and investors.

from GEN

It’s no surprise that Boston/Cambridge, MA, and the San Francisco Bay Area again top this year’s GEN List of the nation’s top 10 biopharma clusters, as they did last year and in 2015. Yet that’s not to say the other eight clusters rounding out the list are the proverbial chopped liver; they too have significant assets that make them attractive to biopharma researchers, executives, and investors, often drawing upon heritages that include the presence of big pharmas or home-grown biotech giants.

Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.

0 likes